MedPath

Octapharma Ag

Octapharma Ag logo
🇨🇷Costa Rica
Ownership
Private
Established
1983-01-01
Employees
10K
Market Cap
-
Website
http://octapharmaag

Clinical Trials

123

Active:112
Completed:6

Trial Phases

5 Phases

Phase 1:52
Phase 2:2
Phase 3:14
+2 more phases

Drug Approvals

12

SFDA:12

Drug Approvals

PANZYGA

Approval Date
Jul 18, 2025
Company
OCTAPHARMA
SFDA

PANZYGA

Approval Date
Jul 18, 2025
Company
OCTAPHARMA
SFDA

PANZYGA

Approval Date
Jul 18, 2025
Company
OCTAPHARMA
SFDA

PANZYGA

Approval Date
Jul 18, 2025
Company
OCTAPHARMA
SFDA

PANZYGA

Approval Date
Jul 18, 2025
Company
OCTAPHARMA
SFDA

PANZYGA

Approval Date
Jul 18, 2025
Company
OCTAPHARMA
SFDA

OCTAPLAS LG 45-70MG/ML

Approval Date
Jul 18, 2025
Company
OCTAPHARMA
SFDA

ALBUNORM

Approval Date
Jul 18, 2025
Company
OCTAPHARMA
SFDA

ALBUNORM 20%

Approval Date
Jul 18, 2025
Company
OCTAPHARMA
SFDA
  • Prev
  • 1
  • 2
  • Next

Clinical Trials

Distribution across different clinical trial phases (70 trials with phase data)• Click on a phase to view related trials

Phase 1
52 (74.3%)
Phase 3
14 (20.0%)
Phase 2
2 (2.9%)
Not Applicable
1 (1.4%)
Phase 4
1 (1.4%)
No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.